JARISLOWSKY FRASER Ltd Has $54.63 Million Position in Relx Plc (NYSE:RELX)

JARISLOWSKY FRASER Ltd raised its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 3.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,202,753 shares of the technology company's stock after purchasing an additional 36,867 shares during the period. JARISLOWSKY FRASER Ltd owned about 0.06% of Relx worth $54,629,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. CENTRAL TRUST Co grew its position in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after buying an additional 529 shares in the last quarter. Transce3nd LLC bought a new position in shares of Relx in the fourth quarter valued at approximately $40,000. Sierra Ocean LLC bought a new stake in Relx in the 4th quarter valued at $43,000. Brown Brothers Harriman & Co. increased its position in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Private Trust Co. NA increased its position in Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after acquiring an additional 199 shares in the last quarter. Institutional investors own 15.02% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on RELX. StockNews.com lowered shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. The Goldman Sachs Group began coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. Finally, Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Relx presently has an average rating of "Buy".

Relx Price Performance

RELX traded up $0.49 on Friday, hitting $54.53. 432,311 shares of the stock were exchanged, compared to its average volume of 707,776. Relx Plc has a 12 month low of $43.28 and a 12 month high of $55.21. The business has a 50-day moving average of $50.99 and a two-hundred day moving average of $48.84. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The firm has a market capitalization of $100.92 billion, a price-to-earnings ratio of 29.32, a PEG ratio of 2.73 and a beta of 0.86.

Relx Increases Dividend

The business also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be issued a $0.5586 dividend. The ex-dividend date is Friday, May 9th. This represents a dividend yield of 1.6%. This is a boost from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.